MedTrace Logo

Tolerance and Efficacy Evaluation of 3 Face Creams

NCT02063971 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2014-02-17

No results posted yet for this study

Summary

The study will evaluate the tolerance and the efficacy on skin comfort of F#1048-082 soothing cream used just after injection procedure and also the tolerance and the efficacy of the F#841-020 anti-age cream on aging parameters compared to baseline and to the F#1374-002 placebo cream (comparison within subjects - half face method) to identify additional benefits delivered by the product compared to a cosmetic procedure.

Conditions

  • Skin Aging

Interventions

OTHER

Soothing (formulation number: F#1048-082) and antiaging creams (F#841-020 and F#1374-002)

Sponsors & Collaborators

  • Adele Sparavigna

    lead OTHER

Principal Investigators

  • ADELE SPARAVIGNA, PHYSICIAN · Derming SRL

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
35 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2014-04-30
Completion
2014-06-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02063971 on ClinicalTrials.gov